Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 1,600 shares, a drop of 97.2% from the November 15th total of 56,900 shares. Based on an average daily volume of 245,500 shares, the days-to-cover ratio is currently 0.0 days.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group began coverage on Merck KGaA in a report on Thursday, September 19th. They issued a “buy” rating for the company.
View Our Latest Stock Report on Merck KGaA
Merck KGaA Trading Down 0.8 %
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
- Five stocks we like better than Merck KGaA
- What Are Dividend Champions? How to Invest in the Champions
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.